Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's Disease

Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's Disease

Alzheimer's disease (AD) is the most common cause of dementia among older people. There are no effective medications currently available to prevent and treat AD and halt disease progression. Monoacylglycerol lipase (MAGL) is the primary enzyme metabolizing the endocannabinoid 2-arachidonoylglyc...

Descrizione completa

Dettagli Bibliografici
Autori principali: Chen, Rongqing, Zhang, Jian, Wu, Yan, Wang, Dongqing, Feng, Guoping, Tang, Ya-Ping, Teng, Zhaoqian, Chen, Chu
Altri autori: Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Natura: Articolo
Lingua:en_US
Pubblicazione: Elsevier B.V. 2014
Accesso online:http://hdl.handle.net/1721.1/91650
https://orcid.org/0000-0002-8021-277X

Accesso online

http://hdl.handle.net/1721.1/91650
https://orcid.org/0000-0002-8021-277X

Documenti analoghi